Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth

Although cisplatin has been shown to be an integral part of chemotherapy regimen in osteosarcoma (OS) treatment, toxicity issues and chemoresistance have hindered therapeutic development for OS. Exploring novel combination therapy methods is needed to circumvent the limitations of cisplatin alone. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Farui, Zhang, Yuanjin, Xu, Lijun, Li, Songbai, Chen, Xiang, Zhang, Ling, Wu, Yifan, Li, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844646/
https://www.ncbi.nlm.nih.gov/pubmed/29191257
http://dx.doi.org/10.3727/096504017X15119525209765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844646/
https://www.ncbi.nlm.nih.gov/pubmed/29191257
http://dx.doi.org/10.3727/096504017X15119525209765

Ejemplares similares